More than two years after acquiring Tarus Therapeutics, Portage Biotech is relaunching Tarus’ adenosine receptor antagonists in a standalone company helmed by a familiar leader. The offshoot, to be ...
Portage Biotech, Inc. has announced the re-launch of its subsidiary, Cyncado Therapeutics, which will operate independently to focus on developing adenosine receptor antagonists aimed at improving ...
Triacontanol (TRIA), a common constituent of plant waxes, was first shown in 1977 to be an active growth substance which at nanomolar concentrations increased the growth and yield of crops. TRIA is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback